IL6 and hyperphosphatemia: These findings suggest the contribution of hyperphosphatemia to skeletal muscle wasting may result from an indirect mechanism that regulates inflammatory cytokines and their pleotropic activities, such as increased liver-derived IL1β and IL6, which might increase overall systemic levels that effectively target skeletal muscle.